2
Clinical Trials associated with HUC-MSCs-Exos (The Second Hospital of Hebei Medical University) / Not yet recruitingNot ApplicableIIT A single-center, single-arm, dose-climbing safety study and multi-center, double-blind, randomized controlled dose-effect clinical study of human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSCs-Exos) in the treatment of ARDS
Start Date31 Oct 2024 |
Sponsor / Collaborator- |
Randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of human umbilical cord MSC–derived exosomes (hUCMSC-Exos) in COVID-19–associated ARDS (Pilot study)
Start Date20 May 2021 |
Sponsor / Collaborator- |
100 Clinical Results associated with HUC-MSCs-Exos (The Second Hospital of Hebei Medical University)
100 Translational Medicine associated with HUC-MSCs-Exos (The Second Hospital of Hebei Medical University)
100 Patents (Medical) associated with HUC-MSCs-Exos (The Second Hospital of Hebei Medical University)
100 Deals associated with HUC-MSCs-Exos (The Second Hospital of Hebei Medical University)